ASLAN Pharmaceuticals

$3.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.14 (-4.01%) Today
-$0.05 (-1.49%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ASLN and other stocks, options, and ETFs commission-free!

About ASLN

ASLAN Pharmaceuticals Limited American Depositary Shares, also called ASLAN Pharmaceuticals, is a clinical-stage oncology-focused biopharmaceutical company, which engages in the development of novel therapeutics. Its pipeline includes varlitinib, ASLAN003, ASLAN004, and ASLAN002.

CEO
Carl Aslan Jason Morton Firth
Employees
—
Headquarters
Singapore, Central Singapore
Founded
2010
Market Cap
229.55M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
711.08K
High Today
$3.50
Low Today
$3.27
Open Price
$3.50
Volume
348.10K
52 Week High
$6.75
52 Week Low
$1.26

ASLN Earnings

-$0.18
-$0.12
-$0.06
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, Pre-Market

You May Also Like

TOL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure